Evaluation of [ 18 F]VUF 5000 as a potential PET ligand for brain imaging of the histamine H 3 receptor
- 1 September 1999
- journal article
- Published by Elsevier in Bioorganic & Medicinal Chemistry
- Vol. 7 (9) , 1761-1767
- https://doi.org/10.1016/s0968-0896(99)00108-x
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Brain penetration of the histamine H3 receptor antagonists thioperamide and clobenpropit in rat and mouse, determined with ex vivo [125I]iodophenpropit bindingBrain Research, 1996
- Approaches towards the synthesis of fluoro(cyclo)alkylaminesJournal of Fluorine Chemistry, 1996
- Rat Protein Binding and Cerebral Phospholipid Affinity of the H3-receptor Antagonist ThioperamideJournal of Pharmacy and Pharmacology, 1996
- Subcortical modulation of synaptic plasticity in the hippocampusBehavioural Brain Research, 1995
- Lipophilicity and hydrogen-bonding capacity of H1-antihistaminic agents in relation to their central sedative side-effectsEuropean Journal of Pharmaceutical Sciences, 1994
- Histamine inhibits dopamine release in the mouse striatum via presynaptic H3 receptorsJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1993
- In vivo occupancy of histamine H3 receptors by thioperamide and (R)-α-methylhistamine measured using histamine turnover and an ex vivo labeling techniqueBiochemical Pharmacology, 1992
- Histamine H3 ligands: just pharmacological tools or potential therapeutic agents?Journal of Medicinal Chemistry, 1990
- Hydrophobicity and Central Nervous System Agents: On the Principle of Minimal Hydrophobicity in Drug DesignJournal of Pharmaceutical Sciences, 1987
- Auto-inhibition of brain histamine release mediated by a novel class (H3) of histamine receptorNature, 1983